SPDR S&P Pharmaceuticals ETF
XPH
XPH
77 hedge funds and large institutions have $261M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 17 closing their positions.
Holders
77
Holders Change
-8
Holders Change %
-9.41%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
29
Reduced
29
Closed
17
Calls
$924K
Puts
$788K
Net Calls
+$136K
Net Calls Change
-$625K
Top Buyers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$19.2M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$21.3M |
3 |
PVH
3
Psagot Value Holdings
Tel Aviv,
Israel
|
$10.1M |
4 |
4
Citigroup
New York
|
$7.43M |
5 |
5
Goldman Sachs
New York
|
$28.8M |